A novel real time imaging platform to quantify macrophage phagocytosis

Biochemical Pharmacology

Volumn 116, Issue , 2016, Pages 107-119

  Kapellos, Theodore S ^a   Taylor, Lewis ^a   Lee, Heyne ^a   Cowley, Sally A ^a   James, William S ^a   Iqbal, Asif J ^a   Greaves, David R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Inflammation; LPS; Macrophage; Phagocytosis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 4; OPSONIN; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; INTERLEUKIN DERIVATIVE;

ACCURACY; ACIDITY; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE; HOMEOSTASIS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PHAGOCYTOSIS; PHAGOLYSOSOME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; IMAGE PROCESSING; IMMUNOLOGY; INDUCED PLURIPOTENT STEM CELL; MACROPHAGE ACTIVATION; MEMBRANE MICROPARTICLE; MICROBIOLOGY; PHYSIOLOGY; RAW 264.7 CELL LINE; STAPHYLOCOCCUS AUREUS; VALIDATION STUDY;

ANIMALS; BONE MARROW CELLS; CELL LINE; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; ENDOTOXINS; ESCHERICHIA COLI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDUCED PLURIPOTENT STEM CELLS; INTERLEUKINS; MACROPHAGE ACTIVATION; MACROPHAGES; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; OPSONIN PROTEINS; PHAGOCYTOSIS; RAW 264.7 CELLS; STAPHYLOCOCCUS AUREUS;

EID: 84983732273     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2016.07.011     Document Type: Article

References (66)

1. [1] Metschnikoff, Elias, Ueber die Beziehung der Phagocyten zu Milzbrandbacillen. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin. 97:3 (1884), 502–526.
2. [2] Chow, A., Brown, B.D., Merad, M., Studying the mononuclear phagocyte system in the molecular age. Nat. Rev. Immunol. 11:11 (2011), 788–798.
3. [3] Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., Beutler, B., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:5396 (1998), 2085–2088.
4. [4] Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., Kimoto, M., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:11 (1999), 1777–1782.
5. [5] Scaffidi, P., Misteli, T., Bianchi, M.E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:6894 (2002), 191–195.
6. [6] Werman, A., Werman-Venkert, R., White, R., Lee, J.K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C.A., Apte, R.N., The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. U.S.A. 101:8 (2004), 2434–2439.
7. [7] Shi, Y., Evans, J.E., Rock, K.L., Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:6957 (2003), 516–521.
8. [8] Holowka, D., Sil, D., Torigoe, C., Baird, B., Insights into immunoglobulin E receptor signaling from structurally defined ligands. Immunol. Rev. 217 (2007), 269–279.
9. [9] Ghazizadeh, S., Bolen, J.B., Fleit, H.B., Physical and functional association of Src-related protein tyrosine kinases with Fc gamma RII in monocytic THP-1 cells. J. Biol. Chem. 269:12 (1994), 8878–8884.
10. [10] Wang, A.V., Scholl, P.R., Geha, R.S., Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn. J. Exp. Med. 180:3 (1994), 1165–1170.
11. [11] Hamada, F., Aoki, M., Akiyama, T., Toyoshima, K., Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils. Proc. Natl. Acad. Sci. U.S.A. 90:13 (1993), 6305–6309.
12. [12] Yeung, T., Terebiznik, M., Yu, L., Silvius, J., Abidi, W.M., Philips, M., Levine, T., Kapus, A., Grinstein, S., Receptor activation alters inner surface potential during phagocytosis. Science 313:5785 (2006), 347–351.
13. [13] Fairn, G.D., Ogata, K., Botelho, R.J., Stahl, P.D., Anderson, R.A., De Camilli, P., Meyer, T., Wodak, S., Grinstein, S., An electrostatic switch displaces phosphatidylinositol phosphate kinases from the membrane during phagocytosis. J. Cell Biol. 187:5 (2009), 701–714.
14. [14] Scott, C.C., Dobson, W., Botelho, R.J., Coady-Osberg, N., Chavrier, P., Knecht, D.A., Heath, C., Stahl, P., Grinstein, S., Phosphatidylinositol-4,5-bisphosphate hydrolysis directs actin remodeling during phagocytosis. J. Cell Biol. 169:1 (2005), 139–149.
15. [15] Desjardins, M., Huber, L.A., Parton, R.G., Griffiths, G., Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124:5 (1994), 677–688.
16. [16] Garin, J., Diez, R., Kieffer, S., Dermine, J.F., Duclos, S., Gagnon, E., Sadoul, R., Rondeau, C., Desjardins, M., The phagosome proteome: insight into phagosome functions. J. Cell Biol. 152:1 (2001), 165–180.
17. [17] Stenmark, H., Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10:8 (2009), 513–525.
18. [18] Beyenbach, K.W., Wieczorek, H., The V-type H+ ATPase: molecular structure and function, physiological roles and regulation. J. Exp. Biol. 209:Pt 4 (2006), 577–589.
19. [19] Flannagan, R.S., Cosio, G., Grinstein, S., Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 7:5 (2009), 355–366.
20. [20] Risso, A., Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukoc. Biol. 68:6 (2000), 785–792.
21. [21] Marim, F.M., Silveira, T.N., Lima, D.S. Jr., Zamboni, D.S., A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PLoS ONE, 5(12), 2010, e15263.
22. [22] Englen, M.D., Valdez, Y.E., Lehnert, N.M., Lehnert, B.E., Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. J. Immunol. Methods 184:2 (1995), 281–283.
23. [23] Fernandes, H.J., Hartfield, E.M., Christian, H.C., Emmanoulidou, E., Zheng, Y., Booth, H., Bogetofte, H., Lang, C., Ryan, B.J., Sardi, S.P., Badger, J., Vowles, J., Evetts, S., Tofaris, G.K., Vekrellis, K., Talbot, K., Hu, M.T., James, W., Cowley, S.A., Wade-Martins, R., ER stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons. Stem Cell Rep. 6:3 (2016), 342–356.
24. [24] van Wilgenburg, B., Browne, C., Vowles, J., Cowley, S.A., Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS ONE, 8(8), 2013.
25. [25] ESSEN BioScience, IncuCyte™ Background Fluorescence Technical Note. < http://www.essenbioscience.com/media/uploads/files/8000-0265-A00_IncuCyte_Background_Fluorescence_Technical_Note.pdf>, (accessed 26.05.2016).
26. [26] Yan, J., Ralston, M.M., Meng, X.M., Bongiovanni, K.D., Jones, A.L., Benndorf, R., Nelin, L.D., Frazier, W.J., Rogers, L.K., Smith, C.V., Liu, Y.S., Glutathione reductase is essential for host defense against bacterial infection. Free Radical Biol. Med. 61 (2013), 320–332.
27. [27] Yan, J., Meng, X., Wancket, L.M., Lintner, K., Nelin, L.D., Chen, B., Francis, K.P., Smith, C.V., Rogers, L.K., Liu, Y., Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps. J. Immunol. 188:5 (2012), 2316–2327.
28. [28] Kim, K., Kim, N.J., Kim, S.Y., Kim, I.H., Kim, K.S., Lee, G.R., Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-kappaB pathway. Infect. Immun. 83:3 (2015), 1150–1161.
29. [29] Campellone, K.G., Welch, M.D., A nucleator arms race: cellular control of actin assembly. Nat. Rev. Mol. Cell Biol. 11:4 (2010), 237–251.
30. [30] Pruyne, D., Evangelista, M., Yang, C., Bi, E., Zigmond, S., Bretscher, A., Boone, C., Role of formins in actin assembly: nucleation and barbed-end association. Science 297:5581 (2002), 612–615.
31. [31] Hoppe, A.D., Swanson, J.A., Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis. Mol. Biol. Cell 15:8 (2004), 3509–3519.
32. [32] May, R.C., Caron, E., Hall, A., Machesky, L.M., Involvement of the Arp2/3 complex in phagocytosis mediated by FcgammaR or CR3. Nat. Cell Biol. 2:4 (2000), 246–248.
33. [33] Linder, S., Hufner, K., Wintergerst, U., Aepfelbacher, M., Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J. Cell Sci. 113:Pt 23 (2000), 4165–4176.
34. [34] Lukacs, G.L., Rotstein, O.D., Grinstein, S., Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H+ “leak”. J. Biol. Chem. 266:36 (1991), 24540–24548.
35. [35] Anderson, C.L., Shen, L., Eicher, D.M., Wewers, M.D., Gill, J.K., Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes. J. Exp. Med. 171:4 (1990), 1333–1345.
36. [36] Ross, G.D., Reed, W., Dalzell, J.G., Becker, S.E., Hogg, N., Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes. J. Leukoc. Biol. 51:2 (1992), 109–117.
37. [37] Nepomuceno, R.R., Tenner, A.J., C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets. J. Immunol. 160:4 (1998), 1929–1935.
38. [38] Wright, S.D., Silverstein, S.C., Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 158:6 (1983), 2016–2023.
39. [39] Zhang, Y., Hoppe, A.D., Swanson, J.A., Coordination of Fc receptor signaling regulates cellular commitment to phagocytosis. Proc. Natl. Acad. Sci. U.S.A. 107:45 (2010), 19332–19337.
40. [40] Wellington, M., Bliss, J.M., Haidaris, C.G., Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment. Infect. Immun. 71:12 (2003), 7228–7231.
41. [41] Kagaya, K., Fukazawa, Y., Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans. Microbiol. Immunol. 25:8 (1981), 807–818.
42. [42] McCullough, K.C., Crowther, J.R., Butcher, R.N., Carpenter, W.C., Brocchi, E., Capucci, L., De Simone, F., Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology 58:3 (1986), 421–428.
43. [43] Celada, A., Cruchaud, A., Perrin, L.H., Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin. Exp. Immunol. 47:3 (1982), 635–644.
44. [44] Kaplan, G., Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand. J. Immunol. 6:8 (1977), 797–807.
45. [45] Allen, L.A., Aderem, A., Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J. Exp. Med. 184:2 (1996), 627–637.
46. [46] Caron, E., Hall, A., Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282:5394 (1998), 1717–1721.
47. [47] Taborda, C.P., Casadevall, A., CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16:6 (2002), 791–802.
48. [48] Le Cabec, V., Carreno, S., Moisand, A., Bordier, C., Maridonneau-Parini, I., Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J. Immunol. 169:4 (2002), 2003–2009.
49. [49] Bobak, D.A., Gaither, T.A., Frank, M.M., Tenner, A.J., Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:4 (1987), 1150–1156.
50. [50] Peiser, Leanne, Gordon, Siamon, Phagocytosis: Enhancement, in eLS. 2001, John Wiley & Sons, Ltd.
51. [51] Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., Amit, I., Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159:6 (2014), 1312–1326.
52. [52] Gosselin, D., Link, V.M., Romanoski, C.E., Fonseca, G.J., Eichenfield, D.Z., Spann, N.J., Stender, J.D., Chun, H.B., Garner, H., Geissmann, F., Glass, C.K., Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159:6 (2014), 1327–1340.
53. [53] Varol, C., Mildner, A., Jung, S., Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33 (2015), 643–675.
54. [54] Gautier, E.L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K.G., Gordonov, S., Mazloom, A.R., Ma'ayan, A., Chua, W.J., Hansen, T.H., Turley, S.J., Merad, M., Randolph, G.J., Consortium Immunological Genome, Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13:11 (2012), 1118–1128.
55. [55] Martinez, F.O., Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep., 6, 2014, 13.
56. [56] Biswas, S.K., Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11:10 (2010), 889–896.
57. [57] Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:3 (2012), 787–795.
58. [58] Li, W., Katz, B.P., Spinola, S.M., Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages. Infect. Immun. 80:12 (2012), 4426–4434.
59. [59] Leidi, M., Gotti, E., Bologna, L., Miranda, E., Rimoldi, M., Sica, A., Roncalli, M., Palumbo, G.A., Introna, M., Golay, J., M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J. Immunol. 182:7 (2009), 4415–4422.
60. [60] Varin, A., Mukhopadhyay, S., Herbein, G., Gordon, S., Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115:2 (2010), 353–362.
61. [61] Liew, F.Y., Xu, D., Brint, E.K., O'Neill, L.A., Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:6 (2005), 446–458.
62. [62] Biswas, S.K., Lopez-Collazo, E., Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30:10 (2009), 475–487.
63. [63] Collins, P.E., Carmody, R.J., The regulation of endotoxin tolerance and its impact on macrophage activation. Crit. Rev. Immunol. 35:4 (2015), 293–323.
64. [64] Foster, S.L., Hargreaves, D.C., Medzhitov, R., Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:7147 (2007), 972–978.
65. [65] del Fresno, C., Garcia-Rio, F., Gomez-Pina, V., Soares-Schanoski, A., Fernandez-Ruiz, I., Jurado, T., Kajiji, T., Shu, C., Marin, E., Gutierrez del Arroyo, A., Prados, C., Arnalich, F., Fuentes-Prior, P., Biswas, S.K., Lopez-Collazo, E., Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 182:10 (2009), 6494–6507.
66. [66] Pena, O.M., Pistolic, J., Raj, D., Fjell, C.D., Hancock, R.E., Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J. Immunol. 186:12 (2011), 7243–7254.